These lines of evidence suggest that constitutive activation of the KEAP1/NRF2 signaling pathway can permit tumor cells to withstand a harsh oxidative external microenvironment, delineating the “double-edged sword” aspect of the KEAP1/NRF2 signaling pathway [81]. This evidence concerns the gene KEAP1 and neoplasm.